Leukemia study looking at LEF1 protein levels
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study is examining levels of a protein called LEF1 in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Researchers want to see if LEF1 can help predict survival and confirm diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with CLL or SLL, a type of blood cancer.
- You were an adult when diagnosed.
- You have a stored tissue sample (from a lymph node, other organ, or bone marrow) that was already tested for LEF1 protein.
- You have already had genetic or chromosome tests done on that sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study creates lab models from blood samples of people with specific mature B-cell blood cancers (CLL, SMZL, HCL) to test new immune and combination treatments. This research may help find more personalized therapies for these diseases.
This study looks at blood tests and genetic markers in people newly diagnosed with chronic lymphocytic leukemia (CLL). It aims to better understand the disease and may help guide future care.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
This study looks at a specific gene variant in people with newly diagnosed chronic lymphocytic leukemia (CLL). It may help researchers understand CLL better and how genetics could affect the disease.
Hear when a new Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.